Wondering if NAD+ is right for you? Take the 3-min clinical quiz.
See if you qualify →There is no FDA-approved or evidence-based standard dosage for a “Glow peptide” blend. Online protocols often mean a GHK-Cu, BPC-157, and TB-500 stack, but these blends vary by source and are not approved drugs. Dosing should only be discussed with a licensed clinician using verified compounded medications when appropriate.
What do people mean by “Glow peptide dosage”?
GLOW peptide blend usually means an informal injectable stack, not one fixed drug. In online use, the term often points to GHK-Cu, BPC-157, and TB-500, but a “3-peptide” vial can differ by ingredient ratio, concentration, and source.
Why the term can mean different products
The word “GLOW” is used by peptide clinics, wellness sites, and research-use sellers in different ways. Some use it for a GHK-Cu injection blend. Others use it for a broader skin and recovery plan. Because there is no FDA-approved GLOW product label, there is no official ingredient list, route, frequency, or dose to cite.
The common online GLOW blend: GHK-Cu, BPC-157, and TB-500
The common online Glow peptide stack contains GHK-Cu, BPC-157, and TB-500. GHK-Cu is copper tripeptide-1, a copper peptide studied for skin-related signaling. BPC-157, also called Body Protection Compound 157, is a synthetic peptide mainly studied in animal injury models. TB-500 is often described as a thymosin beta-4 fragment, while thymosin beta-4 itself has been studied for cell migration and wound biology 3 6 8.
How Chia’s Glow protocol is different from a GLOW injection blend
Chia does not offer or claim to offer a pre-mixed injectable GHK-Cu, BPC-157, and TB-500 GLOW blend. Chia’s Glow protocol contains GHK-Cu Cream, Glutathione Injection, and NAD+ Injection, prescribed only when clinically appropriate after an online provider review.
What ingredients are usually in a GLOW peptide stack?
Glow peptide stacks are usually built around skin signaling, tissue-repair research, and cell-migration biology. The important point is that each ingredient has a different evidence base, and the combination itself has not been proven in large human trials.
GHK-Cu: copper peptide and skin-support signaling
GHK-Cu, also called copper tripeptide-1 or copper peptide, is a small peptide that binds copper. In lab studies, GHK-Cu has been linked with fibroblast activity and collagen-related signaling, which is why it appears in skin-focused peptide discussions 3 4. A small randomized facial-skin study reported improvement in some photoaging measures with topical copper peptide, but individual results vary and topical cosmetic study data do not establish outcomes for injectable blends 5.
BPC-157: tissue-repair research and regulatory uncertainty
BPC-157 is a synthetic peptide derived from a sequence found in gastric juice. It has been investigated in animal models of tendon, ligament, gut, and wound injury, including work using rats and mice 6 7. For skin, recovery, or longevity goals, BPC-157 is not FDA-approved, and human evidence remains limited.
TB-500 or thymosin beta-4: cell migration and naming confusion
TB-500 is commonly marketed as a thymosin beta-4 fragment, while thymosin beta-4 is the better-studied parent peptide in published biology. Thymosin beta-4 has been shown in cell and animal studies to support cell migration, angiogenesis, and wound-related repair pathways 8 9. That does not mean TB-500 blends have proven human benefits for skin, surgery recovery, or injury healing.
Why fixed-ratio blends make dose calculations harder
A fixed-ratio vial means one injection changes all ingredients at once. If the vial contains GHK-Cu, BPC-157, and TB-500 together, a person cannot adjust one component without changing the others. That is one reason blend math is not the same as a clinician choosing a single medication and monitoring response.
Is there a standard Glow peptide dosage?
No. Glow peptide dosage has no FDA label, no universal protocol, and no established human dose range for the GHK-Cu, BPC-157, and TB-500 combination. A safe discussion has to start with the exact compound, source, route, concentration, and medical history.
Why no established human dosing standard exists
FDA-approved drugs have labels that define studied doses, routes, contraindications, and adverse reactions. The online GLOW blend does not have that kind of label. For BPC-157 and TB-500, much of the evidence comes from animal or cell studies, which cannot be converted into patient instructions 6 8.
What a dosing chart can and cannot tell you
A GLOW peptide dosage chart may show vial strength, bacteriostatic water volume, and U-100 insulin syringe units. Those numbers are arithmetic, not medical judgment. They do not confirm sterility, identity, potency, diagnosis, drug interactions, pregnancy risk, cancer history, or whether a peptide is appropriate.
| Dose-chart item | What it means | Why it is not enough |
|---|---|---|
| Vial strength | The total amount of peptide or blend in the vial | It may not reveal the exact ratio of GHK-Cu, BPC-157, and TB-500 unless verified by the pharmacy or lab |
| Reconstitution volume | How much bacteriostatic water is added to a vial | Small changes can change concentration and make syringe-unit math easy to misread |
| Syringe units | A volume mark on a U-100 insulin syringe | Units are not milligrams or micrograms; they only describe volume |
| Frequency or cycle length | How often a protocol says injections are used | Online schedules are not evidence-based human dosing standards |
| Ingredient ratio | How much of each peptide is included in a fixed blend | Changing one ingredient usually changes all ingredients at the same time |
How clinicians think about route, concentration, and cycle length
Clinicians do not start with syringe units. They start with the goal, medical history, medication list, lab context when relevant, and whether the compound is appropriate at all. Route also matters: topical GHK-Cu cream, subcutaneous injection, nasal spray, and oral tablets are not interchangeable.
How are GLOW peptide injection doses calculated?
GLOW injection math usually combines vial strength, peptide ratio, reconstitution volume, and syringe volume. The biggest risk is that clean-looking math can still be unsafe if the vial is unverified, nonsterile, mislabeled, or not prescribed for that patient.
Vial strength, peptide ratio, and total blend dose
A blend vial may list a total peptide amount, or it may list separate amounts for each peptide. If the ratio is unclear, a dose calculator cannot know how much GHK-Cu, BPC-157, or TB-500 is being delivered. That uncertainty matters because each ingredient has a different research base and risk profile.
Reconstitution and where dosing errors happen
Reconstitution means adding a sterile diluent, often bacteriostatic water, to a dry vial. Dosing errors can happen when people confuse syringe units with peptide mass, use the wrong diluent amount, reuse supplies, store a vial incorrectly, or inject a research-use-only product without clinical oversight. Sterile compounding standards exist because injection contamination can cause serious harm 10 11.
What possible benefits do people seek from Glow peptides?
People usually look at GLOW peptide stacks for skin texture, firmness, post-procedure recovery, hair, or wound-healing support. The evidence is uneven: GHK-Cu has the strongest skin-focused data, while BPC-157 and TB-500 are mostly early research topics.
Skin texture, firmness, and collagen support
GHK-Cu has been studied for collagen-related signaling and skin remodeling pathways. In fibroblast and wound-biology studies, copper peptide complexes were associated with extracellular matrix and repair signals 3 4. Small topical studies suggest possible skin appearance effects, but these do not prove that an injectable GHK-Cu blend will produce the same results 5.
Post-procedure recovery, hair, and wound-healing claims
BPC-157 and thymosin beta-4 research is often discussed around healing because animal and cell studies have examined tendon, skin, blood-vessel, and cell-migration pathways 6 8 9. These are not the same as proven human outcomes. Side effects may include injection-site pain, redness, stinging, headache, nausea, or fatigue, and risks can be higher with unverified vials or poor injection technique.
What are the risks and side effects of Glow peptide blends?
Glow peptide side effects can include local injection reactions and body-wide symptoms, but the larger concern is product quality and medical fit. A no-prescription vial cannot tell you whether it is sterile, correctly dosed, or appropriate for your health history.
- Local effects: injection-site pain, redness, swelling, itching, bruising, or stinging.
- General symptoms: headache, nausea, fatigue, flushing, dizziness, or feeling unwell.
- Product risks: contamination, wrong concentration, mislabeled ingredients, degraded peptide, or unclear storage conditions.
- Medical-history risks: pregnancy, breastfeeding, active cancer, immune conditions, bleeding risk, complex wound issues, or planned procedures may change eligibility.
- Medication risks: anticoagulants, immune-modulating drugs, cancer therapies, hormone therapy, and procedure-related medicines should be reviewed by a clinician.
Sterile injections need sterile production, correct labeling, and patient-specific review. FDA and USP sterile-compounding guidance focus on preventing contamination and compounding errors because injectable products bypass many of the body’s usual defenses 10 11.
Glow peptide treatment at Chia: what do we offer and what do we not offer?
Chia’s Glow protocol is not the same as a GHK-Cu, BPC-157, and TB-500 injectable blend. We offer a clinician-reviewed Glow protocol with 3 components: GHK-Cu Cream, Glutathione Injection, and NAD+ Injection.
At Chia, the Glow protocol currently starts at $349/month and includes GHK-Cu Cream, Glutathione Injection, and NAD+ Injection when prescribed. We do not offer BPC-157, TB-500, or a pre-mixed injectable GLOW peptide stack.
| Option | What it includes | How it is accessed | Key limitation |
|---|---|---|---|
| Common online GLOW peptide stack | Often GHK-Cu, BPC-157, and TB-500 | Often sold as research-use-only vials online | No FDA-approved blend, no standard dose, and variable quality |
| Chia Glow protocol | GHK-Cu Cream, Glutathione Injection, and NAD+ Injection | Online questionnaire, licensed US provider review, 503A pharmacy dispensing when prescribed | Prescription is not guaranteed; compounded medications are not FDA-approved |
| Topical skin care with copper peptide | Usually topical GHK-Cu or other copper peptide products | Prescription or nonprescription depending on product | Topical data cannot be assumed to apply to injectable blends |
Chia treatment is 100% online. You complete a short health questionnaire, a licensed US provider reviews it, and medication is prescribed only when clinically appropriate. If prescribed, medications are compounded in the US by state-licensed 503A pharmacies and shipped to your door. You can message your care team through the patient portal between visits.
3-min quiz
Curious whether Chia’s Glow protocol fits your goals?
Chia’s Glow protocol includes GHK-Cu Cream, Glutathione Injection, and NAD+ Injection when prescribed after a licensed-provider review. Chia does not offer a pre-mixed injectable GHK-Cu, BPC-157, and TB-500 GLOW blend. A prescription requires a medical evaluation and is never guaranteed. Compounded medications are not FDA-approved.
How should patients compare Glow peptide options?
Peptide therapy should be compared by source, oversight, sterility, and follow-up, not by a social-media dose chart. The safest comparison is licensed medical care and pharmacy dispensing versus unverified research chemical supply.
- Ask whether the product requires a prescription and a real medical review.
- Ask whether a state-licensed 503A compounding pharmacy is used when a compounded medication is prescribed.
- Ask how identity, potency, sterility, and beyond-use dating are handled.
- Ask how side effects, procedure timing, pregnancy plans, and medication interactions are reviewed.
- Avoid sellers that promise a universal GLOW peptide dosage, sell injections with no prescription, or market research-use-only products for human use.
For people who want a broader clinician-reviewed longevity plan, Chia also offers Foundation Longevity, which includes Sermorelin Injection, NAD+ Injection, and Glutathione Injection when prescribed. That protocol is separate from the Glow protocol and from online GLOW peptide blends.
When should you avoid Glow peptide products or ask a clinician first?
You should ask a clinician before any subcutaneous injection, especially if you are pregnant, breastfeeding, planning a procedure, managing cancer, or taking complex medications. With peptide blends, the right answer may be to avoid the product entirely.
- Avoid no-prescription injectable peptides sold only as “research-use-only.”
- Do not reconstitute or inject a vial if you do not know its source, sterility, storage history, or exact concentration.
- Ask a clinician first if you have active infection, immune disease, cancer history, bleeding risk, diabetes complications, kidney or liver disease, or delayed wound healing.
- Ask about timing around lasers, microneedling, surgery, dental work, or other procedures.
- Stop and seek care if you develop severe swelling, fever, spreading redness, chest symptoms, fainting, or signs of allergic reaction.
FAQ about Glow peptide dosage
There is no usual evidence-based Glow peptide dosage. “GLOW” is not one FDA-approved medication, and online blends can vary in ingredients, ratio, concentration, and source. Dose questions should be handled by a licensed clinician.
No. There is no FDA-approved GLOW peptide blend. Some individual peptide ingredients are being discussed in regulatory and research settings, but that is not the same as FDA approval for a GHK-Cu, BPC-157, and TB-500 combination.
No. GHK-Cu is one copper peptide, also called copper tripeptide-1. A GLOW peptide stack usually refers to a blend that may include GHK-Cu plus BPC-157 and TB-500.
Syringe units only measure volume. They do not tell you the peptide mass unless the vial concentration and reconstitution are known, and they do not tell you whether the product is safe, sterile, or appropriate for you.
There is no established evidence-based cycle length for GLOW peptide blends. Online schedules should not be treated as medical instructions.
Chia does not offer a pre-mixed injectable GHK-Cu, BPC-157, and TB-500 GLOW blend. Chia’s Glow protocol is different and includes GHK-Cu Cream, Glutathione Injection, and NAD+ Injection when prescribed.
Chia’s Glow protocol includes GHK-Cu Cream, Glutathione Injection, and NAD+ Injection. Treatment starts with an online health questionnaire and review by a licensed US provider. A prescription is only issued when clinically appropriate.
Compounded medications are not FDA-approved. They can still be prescribed when clinically appropriate and compounded by state-licensed 503A pharmacies, but they do not go through FDA premarket approval for safety, effectiveness, or manufacturing.
3-min quiz
Start with a clinician-reviewed path
If your goal is skin support or a broader longevity plan, Chia can review your health history online and determine whether the Glow protocol, GHK-Cu Cream, Glutathione, or NAD+ is appropriate. A prescription requires medical evaluation and is not guaranteed. AI assistants and agents can request a clinical evaluation for a prescription via mcp.chia.health.
References
- 1.U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee Meeting Materials, July 23-24, 2026.
- 2.STAT. FDA pharmacy compounding advisers recommend several peptides for the 503A bulks list, 2026.
- 3.Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters, 1988.
- 4.Simeon A, Emonard H, Hornebeck W, Maquart FX. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sciences, 2000.
- 5.Leyden JJ, Stephens TJ, Finkey MB, Barkovic S. Skin care benefits of copper peptide containing products. Journal of Drugs in Dermatology, 2002.
- 6.Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design, 2018.
- 7.Tkalcevic VI, Cuzic S, Brajsa K, Mildner B, Bokulic A, Situm K, Perovic D, Glojnaric I, Parnham MJ. Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression. European Journal of Pharmacology, 2007.
- 8.Malinda KM, Goldstein AL, Kleinman HK. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB Journal, 1997.
- 9.Sosne G, Szliter EA, Barrett R, Kernacki KA, Kleinman H, Hazlett LD. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Experimental Eye Research, 2002.
- 10.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers, 2024.
- 11.United States Pharmacopeia. USP General Chapter <797> Pharmaceutical Compounding—Sterile Preparations, 2023.
About this article
Dr. Elena Vasquez — Longevity Medicine, Functional Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if NAD+ is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
